Neuronetics, Inc.

NASDAQ:STIM

Medical - Diagnostics & Research

Healthcare
$1.24 +0.31%

+$0.00 today

Market cap
$96.38M
Beta
1.04
P/E (TTM)
-2.3
EPS (TTM)
-$0.53
52W Low $0.80High $4.85

Volume 1.66M

Average 2.44M

Income Statement

Follow revenue through to earnings.

Revenue

$149.16M

FY 2025 · Annual

+99.2% YoY

Operating Income

-$31.44M

FY 2025 · Annual

Net Income

-$39.00M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue55.31M65.21M71.35M74.89M149.16M
Cost of Revenue11.65M15.48M19.64M20.73M76.85M
Gross Profit43.66M49.72M51.71M54.16M72.31M
Gross Margin78.9%76.3%72.5%72.3%48.5%
Research & Development7.92M9.34M9.52M12.77M6.58M
Selling, General & Admin63.3M75.5M72.74M75.95M97.16M
Operating Expenses71.22M84.83M82.26M88.72M103.74M
Depreciation & Amortization1.06M1.65M2.01M2.07M3.47M
EBITDA(26.81M)(31.96M)(22.76M)(34.37M)(27.12M)
EBITDA Margin-48.5%-49.0%-31.9%-45.9%-18.2%
Operating Income(27.56M)(35.11M)(30.55M)(34.56M)(31.44M)
Operating Margin-49.8%-53.8%-42.8%-46.2%-21.1%
Interest Income0024K00
Interest Expense3.3M3.6M5.42M7.29M8.42M
Other Income / Expenses(3.61M)(2.1M)365K(9.18M)(7.56M)
Income Before Tax(31.17M)(37.21M)(30.19M)(43.74M)(39M)
Pre-Tax Margin-56.4%-57.1%-42.3%-58.4%-26.1%
Income Tax Expense00(24K)(14K)0
Net Income(31.19M)(37.16M)(30.19M)(43.71M)(39M)
Net Margin-56.4%-57.0%-42.3%-58.4%-26.1%
EPS (Basic)(1.22)(1.38)(1.05)(1.38)(0.59)
EPS (Diluted)(1.22)(1.38)(1.05)(1.38)(0.59)
Weighted Avg Shares25.48M26.9M28.66M31.73M65.95M
Weighted Avg Shares (Diluted)25.48M26.9M28.66M31.73M65.95M

STIM Earnings Waterfall · TTM

NASDAQ:STIM · Revenue to Net Income

Key Ratios

EPS$-0.54
Gross Margin47.8%
Net Margin-24.8%
P/E Ratio-4.1
P/S Ratio4.0

Analysis

$151.6M of revenue converted into -$37.1M of net income for the selected period. Gross margin is 47.8% and net margin is -24.8%, showing how much revenue survives after costs and taxes. EPS is $-0.54, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 13, 2026
8-KCurrent reportNov 12, 2026
424B5424B5 filingNov 12, 2026
8-K/A8-K/A filingNov 12, 2026
8-KCurrent reportNov 10, 2026

How much revenue does STIM generate?

Neuronetics, Inc. (STIM) reported $149.16M of revenue in fiscal 2025.

Is STIM profitable?

Neuronetics, Inc. (STIM) reported -$39.00M of net income, with a net margin of -26.1%.